Insider · CIK 0001277967

MCLAUGHLIN JOHN PETER

Reports to the SEC for 6 companies · BOTHELL, WA

sec.gov

Transactions

Companies

Filings

CIK

0001277967

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-05-25	LNSRLENSAR, Inc.A Award	Director	AAward	+9,288 sh	—	—	53,631
2023-05-25	LNSRLENSAR, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33.2K sh	—	—	33,175
2022-05-25	LNSRLENSAR, Inc.A Award	Director	AAward	+4,285 sh	—	—	44,343
2022-05-25	LNSRLENSAR, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,616
2021-06-17	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+50K sh	—	—	136,974
2021-06-17	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+72.9K sh	—	—	72,857
2021-05-18	LNSRLENSAR, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.8K sh	—	—	20,847
2021-03-12	LNSRLENSAR, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,445
2021-02-01	LNSRLENSAR, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.2K sh	—	—	28,249
2020-12-22	PDL BIOPHARMA, INC.S Sale	Director	SSale	−278K sh	$2.61	−$725K	200,000
2020-12-21	PDL BIOPHARMA, INC.S Sale	Director	SSale	−50K sh	$2.62	−$131K	477,934
2020-08-19	PDL BIOPHARMA, INC.A Award	Director	AAward	+25.8K sh	—	—	527,934
2020-08-19	PDL BIOPHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+119K sh	$3.63	+$431K	118,671
2020-05-18	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+51.8K sh	—	—	86,974
2020-05-18	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,024
2020-01-29	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+12.6K sh	—	—	35,174
2019-09-05	RMTIROCKWELL MEDICAL, INC.A Award	Director	AAward	+22.6K sh	—	—	22,559
2019-09-05	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+28.4K sh	—	—	28,372
2019-06-20	PDL BIOPHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+126K sh	$3.00	+$378K	126,050
2018-12-31	PDL BIOPHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−123K sh	—	—	502,108
2018-12-27	PDL BIOPHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−627K sh	—	—	625,557
2018-06-08	PDL BIOPHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+1.92M sh	—	—	1,922,100
2017-12-15	PDL BIOPHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−152K sh	—	—	1,252,785
2017-03-04	PDL BIOPHARMA, INC.A Award	Director	AAward	+588K sh	$2.04	+$1.2M	1,404,463
2016-12-13	PDL BIOPHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−5,168 sh	—	—	816,228
2016-05-20	Seagen Inc.A Award	Director	AAward	+3,700 sh	—	—	39,400
2016-05-20	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,260 sh	—	—	9,260
2016-02-12	Adverum Biotechnologies, Inc.A Award	Director	AAward	+8,333 sh	—	—	10,333
2016-02-12	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,905
2016-01-26	PDL BIOPHARMA, INC.A Award	Director	AAward	+404K sh	$3.22	+$1.3M	821,396
2015-05-15	Seagen Inc.A Award	Director	AAward	+3,700 sh	—	—	35,700
2015-05-15	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,260 sh	—	—	9,260
2015-04-21	Adverum Biotechnologies, Inc.A Award	Director	AAward	+2,000 sh	—	—	2,000
2015-04-21	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2015-01-28	PDL BIOPHARMA, INC.A Award	Director	AAward	+129K sh	$7.62	+$985K	417,669
2014-08-05	Adverum Biotechnologies, Inc.C Conversion	Director	CConversion	+13.3K sh	—	—	13,280
2014-08-05	Adverum Biotechnologies, Inc.C Conversion	Director	CConversion	+13.3K sh	—	—	13,280
2014-08-05	Adverum Biotechnologies, Inc.Series B Preferred StockC Conversion	Director	CConversion	−13.3K sh	—	—	0
2014-08-05	Adverum Biotechnologies, Inc.Series B Preferred StockC Conversion	Director	CConversion	−13.3K sh	—	—	0
2014-07-30	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2013-05-17	Seagen Inc.A Award	Director	AAward	+3,500 sh	—	—	28,500
2013-05-17	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+8,750 sh	$36.70	+$321K	8,750
2013-01-24	PDL BIOPHARMA, INC.A Award	Director	AAward	+29.9K sh	$6.72	+$201K	168,698
2012-05-18	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	$20.06	+$351K	17,500
2012-01-18	PDL BIOPHARMA, INC.A Award	Director	AAward	+32K sh	$6.29	+$201K	138,787
2011-09-09	Seagen Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$9.82	+$246K	25,000
2011-09-09	Seagen Inc.Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2011-05-23	PDL BIOPHARMA, INC.A Award	Director	AAward	+30.5K sh	—	—	106,832
2011-05-20	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	$19.02	+$333K	17,500
2010-05-21	Seagen Inc.Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	$12.76	+$223K	17,500

Recent filings

Accepted (ET)
May 304
MCLAUGHLIN JOHN PETER0000899243-23-014079
SEC(opens sec.gov)
May 274
MCLAUGHLIN JOHN PETER0000899243-22-020055
SEC(opens sec.gov)
Jun 224
MCLAUGHLIN JOHN PETER0001628280-21-012668
SEC(opens sec.gov)
May 204
MCLAUGHLIN JOHN PETER0000899243-21-020137
SEC(opens sec.gov)
Mar 164
MCLAUGHLIN JOHN PETER0000899243-21-011932
SEC(opens sec.gov)
Feb 24
MCLAUGHLIN JOHN PETER0000899243-21-004175
SEC(opens sec.gov)
Dec 224
MCLAUGHLIN JOHN PETER0000882104-20-000213
SEC(opens sec.gov)
Aug 244
MCLAUGHLIN JOHN PETER0000882104-20-000134
SEC(opens sec.gov)
May 204
MCLAUGHLIN JOHN PETER0001628280-20-008126
SEC(opens sec.gov)
Jan 314
MCLAUGHLIN JOHN PETER0001104659-20-009242
SEC(opens sec.gov)
Sep 64
MCLAUGHLIN JOHN PETER0001104659-19-049098
SEC(opens sec.gov)
Jul 84
MCLAUGHLIN JOHN PETER0000882104-19-000082
SEC(opens sec.gov)
Jan 94
MCLAUGHLIN JOHN PETER0000882104-19-000004
SEC(opens sec.gov)

Companies

Address

21823 30TH DRIVE SE

BOTHELL, WA, 98021